The central laboratory of ACM Global, a clinical trials testing service, has been relocated its laboratory facilities in York, England.
The move to a larger facility is in response to growing client demand for ACM Global’s clinical trials testing services throughout Europe, including Western and Eastern Europe, as well as South Africa and the Middle East.
The new, state-of-the-art facility offers 14,500 square feet of laboratory and office space, nearly twice the size of ACM Global’s previous facility in York, and accommodates ACM Global’s expanding laboratory operations, as well as its growing staff of data analysts, project managers and quality assurance specialists.
“Our new facility enables us to continue our growth in the European market and to expand the menu of clinical trials testing services we offer our clients,” said Jerry Boxall, managing director, Europe, ACM Global Central Laboratory. “We are excited with the prospects offered by our new facility, which has been purpose-built to optimize our laboratory processes. The additional space enhances our ability to continue to meet the needs of our clients with high-quality laboratory services, while positioning us to take advantage of new opportunities in the market.”
Angela J. Panzarella, president of ACM Medical Laboratory, the parent company of ACM Global Central Laboratory. “Expansion of our European laboratory hub represents a significant investment by our company, driven by our growth over the last several years. We have enjoyed robust growth in our European and global business, and the new facility represents our commitment to the region and to continuous improvement of the services we offer our clients.”